Literature DB >> 11136726

Physical interaction between the MADS box of serum response factor and the TEA/ATTS DNA-binding domain of transcription enhancer factor-1.

M Gupta1, P Kogut, F J Davis, N S Belaguli, R J Schwartz, M P Gupta.   

Abstract

Serum response factor is a MADS box transcription factor that binds to consensus sequences CC(A/T)(6)GG found in the promoter region of several serum-inducible and muscle-specific genes. In skeletal myocytes serum response factor (SRF) has been shown to heterodimerize with the myogenic basic helix-loop-helix family of factors, related to MyoD, for control of muscle gene regulation. Here we report that SRF binds to another myogenic factor, TEF-1, that has been implicated in the regulation of a variety of cardiac muscle genes. By using different biochemical assays such as affinity precipitation of protein, GST-pulldown assay, and coimmunoprecipitation of proteins, we show that SRF binds to TEF-1 both in in vitro and in vivo assay conditions. A strong interaction of SRF with TEF-1 was seen even when one protein was denatured and immobilized on nitrocellulose membrane, indicating a direct and stable interaction between SRF and TEF-1, which occurs without a cofactor. This interaction is mediated through the C-terminal subdomain of MADS box of SRF encompassing amino acids 204-244 and the putative 2nd and 3rd alpha-helix/beta-sheet configuration of the TEA/ATTS DNA-binding domain of TEF-1. In the transient transfection assay, a positive cooperative effect of SRF and TEF-1 was observed when DNA-binding sites for both factors, serum response element and M-CAT respectively, were intact; mutation of either site abolished their synergistic effect. Similarly, an SRF mutant, SRFpm-1, defective in DNA binding failed to collaborate with TEF-1 for gene regulation, indicating that the synergistic trans-activation function of SRF and TEF-1 occurs via their binding to cognate DNA-binding sites. Our results demonstrate a novel association between SRF and TEF-1 for cardiac muscle gene regulation and disclose a general mechanism by which these two super families of factors are likely to control diversified biological functions.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  2001        PMID: 11136726     DOI: 10.1074/jbc.M008625200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.

Authors:  Asokan Anbanandam; Diana C Albarado; Catherine T Nguyen; Georg Halder; Xiaolian Gao; Sudha Veeraraghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

2.  A TEAD1/p65 complex regulates the eutherian-conserved MnSOD intronic enhancer, eRNA transcription and the innate immune response.

Authors:  Ann L Chokas; Justin S Bickford; Sarah J Barilovits; Richard J Rogers; Xiaolei Qiu; Kimberly J Newsom; Dawn E Beachy; Harry S Nick
Journal:  Biochim Biophys Acta       Date:  2014-06-19

3.  Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Authors:  Charis L Himeda; Céline Debarnot; Sachiko Homma; Mary Lou Beermann; Jeffrey B Miller; Peter L Jones; Takako I Jones
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

4.  A Potential Structural Switch for Regulating DNA-Binding by TEAD Transcription Factors.

Authors:  Dong-Sun Lee; Clemens Vonrhein; Diana Albarado; C S Raman; Sudha Veeraraghavan
Journal:  J Mol Biol       Date:  2016-03-22       Impact factor: 5.469

5.  Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.

Authors:  Aibin He; Sek Won Kong; Qing Ma; William T Pu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-17       Impact factor: 11.205

6.  Structural and functional analysis of the related transcriptional enhancer factor-1 and NF-κB interaction.

Authors:  Jieliang Ma; Li Zhang; Aaron R Tipton; Jiaping Wu; Angela F Messmer-Blust; Melissa J Philbrick; Yajuan Qi; Song-Tao Liu; Hongsheng Liu; Jian Li; Shaodong Guo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-08       Impact factor: 4.733

7.  Alternative requirements for Vestigial, Scalloped, and Dmef2 during muscle differentiation in Drosophila melanogaster.

Authors:  Hua Deng; Sarah C Hughes; John B Bell; Andrew J Simmonds
Journal:  Mol Biol Cell       Date:  2008-11-05       Impact factor: 4.138

8.  Sequencing of mRNA identifies re-expression of fetal splice variants in cardiac hypertrophy.

Authors:  E G Ames; M J Lawson; A J Mackey; J W Holmes
Journal:  J Mol Cell Cardiol       Date:  2013-05-17       Impact factor: 5.000

Review 9.  Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure.

Authors:  Mahesh P Gupta
Journal:  J Mol Cell Cardiol       Date:  2007-07-21       Impact factor: 5.000

10.  Vestigial-like-2b (VITO-1b) and Tead-3a (Tef-5a) expression in zebrafish skeletal muscle, brain and notochord.

Authors:  Christopher J Mann; Daniel P S Osborn; Simon M Hughes
Journal:  Gene Expr Patterns       Date:  2007-08-15       Impact factor: 1.224

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.